Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma.


Journal

Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630

Informations de publication

Date de publication:
12 2020
Historique:
received: 03 05 2020
revised: 04 08 2020
accepted: 24 08 2020
pubmed: 13 9 2020
medline: 16 4 2021
entrez: 12 9 2020
Statut: ppublish

Résumé

Esophageal adenocarcinoma (EA) and its premalignant lesion, Barrett's esophagus (BE), are characterized by a strong and yet unexplained male predominance (with a male-to-female ratio in EA incidence of up to 6:1). Genome-wide association studies (GWAS) have identified more than 20 susceptibility loci for these conditions. However, potential sex differences in genetic associations with BE/EA remain largely unexplored. Given strong genetic overlap, BE and EA cases were combined into a single case group for analysis. These were compared with population-based controls. We performed sex-specific GWAS of BE/EA in 3 separate studies and then used fixed-effects meta-analysis to provide summary estimates for >9 million variants for male and female individuals. A series of downstream analyses were conducted separately in male and female individuals to identify genes associated with BE/EA and the genetic correlations between BE/EA and other traits. We included 6758 male BE/EA cases, 7489 male controls, 1670 female BE/EA cases, and 6174 female controls. After Bonferroni correction, our meta-analysis of sex-specific GWAS identified 1 variant at chromosome 6q11.1 (rs112894788, KHDRBS2-MTRNR2L9, P The identified novel sex-specific variants associated with BE/EA could improve the understanding of the genetic architecture of the disease and the reasons for the male predominance.

Sections du résumé

BACKGROUND & AIMS
Esophageal adenocarcinoma (EA) and its premalignant lesion, Barrett's esophagus (BE), are characterized by a strong and yet unexplained male predominance (with a male-to-female ratio in EA incidence of up to 6:1). Genome-wide association studies (GWAS) have identified more than 20 susceptibility loci for these conditions. However, potential sex differences in genetic associations with BE/EA remain largely unexplored.
METHODS
Given strong genetic overlap, BE and EA cases were combined into a single case group for analysis. These were compared with population-based controls. We performed sex-specific GWAS of BE/EA in 3 separate studies and then used fixed-effects meta-analysis to provide summary estimates for >9 million variants for male and female individuals. A series of downstream analyses were conducted separately in male and female individuals to identify genes associated with BE/EA and the genetic correlations between BE/EA and other traits.
RESULTS
We included 6758 male BE/EA cases, 7489 male controls, 1670 female BE/EA cases, and 6174 female controls. After Bonferroni correction, our meta-analysis of sex-specific GWAS identified 1 variant at chromosome 6q11.1 (rs112894788, KHDRBS2-MTRNR2L9, P
CONCLUSIONS
The identified novel sex-specific variants associated with BE/EA could improve the understanding of the genetic architecture of the disease and the reasons for the male predominance.

Identifiants

pubmed: 32918910
pii: S0016-5085(20)35130-1
doi: 10.1053/j.gastro.2020.08.052
pmc: PMC9057456
mid: NIHMS1627421
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
Eye Proteins 0
KHDRBS2 protein, human 0
Prss55 protein, human 0
RNA-Binding Proteins 0
RP1L1 protein, human 0
Serine Endopeptidases EC 3.4.21.-

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2065-2076.e1

Subventions

Organisme : NCI NIH HHS
ID : K05 CA124911
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK034987
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK063616
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA091955
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA136725
Pays : United States
Organisme : NIDDK NIH HHS
ID : R21 DK077742
Pays : United States

Investigateurs

Jing Dong (J)
Carlo Maj (C)
Spiridon Tsavachidis (S)
Quinn T Ostrom (QT)
Puya Gharahkhani (P)
Lesley A Anderson (LA)
Anna H Wu (AH)
Weimin Ye (W)
Leslie Bernstein (L)
Oleg Borisov (O)
Julia Schröder (J)
Wong-Ho Chow (WH)
Marilie D Gammon (MD)
Geoffrey Liu (G)
Carlos Caldas (C)
Paul D Pharoah (PD)
Harvey A Risch (HA)
Andrea May (A)
Christian Gerges (C)
Mario Anders (M)
Marino Venerito (M)
Thomas Schmidt (T)
Jakob R Izbicki (JR)
Arnulf H Hölscher (AH)
Brigitte Schumacher (B)
Yogesh Vashist (Y)
Horst Neuhaus (H)
Thomas Rösch (T)
Michael Knapp (M)
Peter Krawitz (P)
Anne Böhmer (A)
Prasad G Iyer (PG)
Brian J Reid (BJ)
Jesper Lagergren (J)
Nicholas J Shaheen (NJ)
Douglas A Corley (DA)
Ines Gockel (I)
Rebecca C Fitzgerald (RC)
Michael B Cook (MB)
David C Whiteman (DC)
Thomas L Vaughan (TL)
Johannes Schumacher (J)
Aaron P Thrift (AP)

Informations de copyright

Copyright © 2020 AGA Institute. All rights reserved.

Références

Mod Pathol. 2009 Feb;22(2):261-72
pubmed: 18953328
Brain. 2019 Sep 1;142(9):2581-2589
pubmed: 31497858
Mol Neurobiol. 2017 Dec;54(10):8021-8032
pubmed: 27878761
Lancet Oncol. 2016 Oct;17(10):1363-1373
pubmed: 27527254
Breast Cancer. 2014 Nov;21(6):715-23
pubmed: 23381229
Ann Oncol. 2017 Mar 1;28(3):604-610
pubmed: 27993815
Clin Gastroenterol Hepatol. 2016 Mar;14(3):338-347.e1
pubmed: 26484704
Clin Cancer Res. 2017 May 1;23(9):2335-2345
pubmed: 28151721
J Biol Chem. 2000 Apr 28;275(17):13000-6
pubmed: 10777602
Acta Neuropathol. 2018 Dec;136(6):857-872
pubmed: 29967939
J Natl Cancer Inst. 2019 Jan 1;111(1):34-41
pubmed: 29788475
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4631-E4640
pubmed: 28533408
PLoS Comput Biol. 2015 Apr 17;11(4):e1004219
pubmed: 25885710
Nat Commun. 2018 May 8;9(1):1825
pubmed: 29739930
Am J Epidemiol. 2005 Dec 1;162(11):1050-61
pubmed: 16221805
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):427-433
pubmed: 31748258
Mol Cancer Res. 2010 Sep;8(9):1198-206
pubmed: 20736295
Am J Transl Res. 2015 Jul 15;7(7):1271-9
pubmed: 26328011
Dig Dis Sci. 2018 Aug;63(8):1988-1996
pubmed: 29671158
BMC Cancer. 2015 Nov 10;15:885
pubmed: 26555036
J Natl Cancer Inst. 2013 Nov 20;105(22):1711-8
pubmed: 24168968
Am J Gastroenterol. 2020 Feb;115(2):216-223
pubmed: 31658123
Nat Genet. 2012 Jul 22;44(8):955-9
pubmed: 22820512
Onco Targets Ther. 2018 Feb 14;11:781-789
pubmed: 29497310
Mol Neurobiol. 2018 May;55(5):4403-4416
pubmed: 28660485
Int J Cancer. 2013 May 1;132(9):1986-95
pubmed: 23023514
PLoS One. 2010 Dec 30;5(12):e16010
pubmed: 21209860
J Biol Chem. 2008 Apr 4;283(14):9399-413
pubmed: 18218617
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Nat Genet. 2015 Mar;47(3):291-5
pubmed: 25642630
Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):243-8
pubmed: 25666644
Clin Gastroenterol Hepatol. 2016 Mar;14(3):330-2
pubmed: 26528803
Am Heart J. 2002 Aug;144(2):212-8
pubmed: 12177636
Nucleic Acids Res. 2012 Jan;40(Database issue):D930-4
pubmed: 22064851
PLoS One. 2018 Jan 17;13(1):e0190325
pubmed: 29342161
Nat Genet. 2012 Mar 18;44(4):369-75, S1-3
pubmed: 22426310
Nat Rev Genet. 2008 Dec;9(12):911-22
pubmed: 19002143
Nat Rev Genet. 2019 Mar;20(3):173-190
pubmed: 30581192
Gut. 2009 Feb;58(2):182-8
pubmed: 18978173
PLoS One. 2014 Jul 30;9(7):e103508
pubmed: 25075959
Gastroenterology. 2015 Feb;148(2):367-78
pubmed: 25447851
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
Gastroenterology. 2018 Apr;154(5):1273-1281.e3
pubmed: 29247777
Sci Rep. 2015 Sep 02;5:13750
pubmed: 26330360
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Gastroenterol Clin North Am. 2016 Dec;45(4):615-624
pubmed: 27837776
Nat Rev Cancer. 2009 Mar;9(3):182-94
pubmed: 19194382
Gut. 2015 Mar;64(3):381-7
pubmed: 25320104
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Genome Res. 2012 Sep;22(9):1790-7
pubmed: 22955989
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Cancer Causes Control. 2005 Apr;16(3):285-94
pubmed: 15947880
JAMA Netw Open. 2018 Aug;1(4):e181670
pubmed: 30294719
Nat Genet. 2013 Dec;45(12):1487-93
pubmed: 24121790
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
Ann Oncol. 2012 Dec;23(12):3155-3162
pubmed: 22847812
Nat Genet. 2012 Oct;44(10):1131-6
pubmed: 22961001
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
BMC Cancer. 2015 Apr 12;15:272
pubmed: 25884948
PLoS Genet. 2012;8(12):e1003098
pubmed: 23284291
Br J Cancer. 2010 Aug 24;103(5):735-40
pubmed: 20700121
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Br J Cancer. 2008 Nov 4;99(9):1506-10
pubmed: 18841152
Bioinformatics. 2017 Jan 15;33(2):272-279
pubmed: 27663502
Clin Gastroenterol Hepatol. 2015 Apr;13(4):673-82
pubmed: 25158929
Genet Epidemiol. 2010 Sep;34(6):591-602
pubmed: 20718045
Sci Rep. 2018 May 9;8(1):7352
pubmed: 29743610
Gastroenterology. 2012 Apr;142(4):744-53
pubmed: 22245667
Cold Spring Harb Perspect Med. 2012 May;2(5):a006627
pubmed: 22553494
Nature. 2007 Jun 7;447(7145):661-78
pubmed: 17554300
Biomed Pharmacother. 2020 Jan;121:109562
pubmed: 31707341
J Natl Cancer Inst. 2010 Sep 8;102(17):1344-53
pubmed: 20716718
Gut. 2017 Oct;66(10):1739-1747
pubmed: 27486097
Nat Genet. 2018 Oct;50(10):1412-1425
pubmed: 30224653
Am J Gastroenterol. 2013 Jun;108(6):915-22
pubmed: 23567358
Gut. 2013 Dec;62(12):1684-91
pubmed: 23355549
J Exp Clin Cancer Res. 2018 Sep 15;37(1):228
pubmed: 30219064
Nat Cell Biol. 2002 Aug;4(8):583-91
pubmed: 12134159
PLoS One. 2019 Dec 31;14(12):e0227072
pubmed: 31891614
Oncotarget. 2016 Jun 21;7(25):38876-38883
pubmed: 27145283
Cancer Res. 2005 Jun 1;65(11):4587-97
pubmed: 15930276
Biochem Biophys Res Commun. 2010 Feb 12;392(3):252-7
pubmed: 19995558
Gastroenterology. 2018 Jan;154(2):390-405
pubmed: 28780073
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2177-82
pubmed: 20080664
Genet Epidemiol. 2011 Jan;35(1):11-8
pubmed: 21181894
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
Int J Mol Med. 2018 May;41(5):2755-2763
pubmed: 29436606
Nat Genet. 2007 Jul;39(7):906-13
pubmed: 17572673
PLoS One. 2011 May 05;6(5):e19297
pubmed: 21573214
Genet Epidemiol. 2010 Dec;34(8):846-53
pubmed: 21104887
Nat Methods. 2011 Dec 04;9(2):179-81
pubmed: 22138821
Int J Epidemiol. 2012 Dec;41(6):1706-18
pubmed: 23148106
Nat Genet. 2019 Feb;51(2):237-244
pubmed: 30643251
Drug Metab Rev. 2011 May;43(2):300-6
pubmed: 21495795
Cell Death Dis. 2019 Jan 15;10(2):33
pubmed: 30674889

Auteurs

Jing Dong (J)

Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas; Division of Hematology and Oncology, Department of Medicine, Cancer Center, and Genomic Sciences & Precision Medicine Center, Medical College of Wisconsin, Milwaukee, Wisconsin.

Carlo Maj (C)

Institute for Genomic Statistics and Bioinformatics, Medical Faculty, University of Bonn, Germany.

Spiridon Tsavachidis (S)

Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.

Quinn T Ostrom (QT)

Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.

Puya Gharahkhani (P)

Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Lesley A Anderson (LA)

Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland & Aberdeen Center for Health Data Science, University of Aberdeen, Scotland.

Anna H Wu (AH)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.

Weimin Ye (W)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Leslie Bernstein (L)

Department of Population Sciences, Beckman Research Institute and City of Hope Comprehensive Cancer Center, Duarte, California.

Oleg Borisov (O)

Institute for Genomic Statistics and Bioinformatics, Medical Faculty, University of Bonn, Germany.

Julia Schröder (J)

Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.

Wong-Ho Chow (WH)

Department of Epidemiology, MD Anderson Cancer Center, Houston, Texas.

Marilie D Gammon (MD)

Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina.

Geoffrey Liu (G)

Pharmacogenomic Epidemiology, Ontario Cancer Institute, Toronto, Ontario, Canada.

Carlos Caldas (C)

Cancer Research UK, Cambridge Institute, Cambridge, UK.

Paul D Pharoah (PD)

Department of Oncology, University of Cambridge, Cambridge, UK; Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Harvey A Risch (HA)

Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.

Andrea May (A)

Department of Medicine II, Sana Klinikum, Offenbach, Germany.

Christian Gerges (C)

Department of Internal Medicine II, Evangelisches Krankenhaus, Düsseldorf, Germany.

Mario Anders (M)

Department of Gastroenterology and Interdisciplinary Endoscopy, Vivantes Wenckebach-Klinikum, Berlin, Germany.

Marino Venerito (M)

Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, Germany.

Thomas Schmidt (T)

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Jakob R Izbicki (JR)

Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany.

Arnulf H Hölscher (AH)

Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany.

Brigitte Schumacher (B)

Department of Internal Medicine and Gastroenterology, Elisabeth Hospital, Essen, Germany.

Yogesh Vashist (Y)

Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany.

Horst Neuhaus (H)

Department of Internal Medicine II, Evangelisches Krankenhaus, Düsseldorf, Germany.

Thomas Rösch (T)

Department of Interdisciplinary Endoscopy, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

Michael Knapp (M)

Institute of Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany.

Peter Krawitz (P)

Institute for Genomic Statistics and Bioinformatics, Medical Faculty, University of Bonn, Germany.

Anne Böhmer (A)

Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany.

Prasad G Iyer (PG)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

Brian J Reid (BJ)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Jesper Lagergren (J)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.

Nicholas J Shaheen (NJ)

Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

Douglas A Corley (DA)

Division of Research, Kaiser Permanente Northern California, Oakland, California; San Francisco Medical Center, Kaiser Permanente Northern California, San Francisco, California.

Ines Gockel (I)

Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany.

Rebecca C Fitzgerald (RC)

Medical Research Council (MRC) Cancer Unit, Hutchison-MRC Research Centre, University of Cambridge, Cambridge, UK.

Michael B Cook (MB)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.

David C Whiteman (DC)

Cancer Control, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Thomas L Vaughan (TL)

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Johannes Schumacher (J)

Center for Human Genetics, University Hospital of Marburg, Marburg, Germany.

Aaron P Thrift (AP)

Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas; Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas. Electronic address: aaron.thrift@bcm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH